1. Home >
  2. M&A >
  3. Divestiture >
  4. Canada >
  5. British Columbia >
  6. PanGenomic Acquires Mindleap Health

M&A Deal Summary

PanGenomic Acquires Mindleap Health

On November 21, 2022, PanGenomic acquired healthcare services company Mindleap Health from Mydecine Innovations Group for 4M CAD

Acquisition Highlights
  • This is PanGenomic’s 1st transaction in the Healthcare Services sector.
  • This is PanGenomic’s largest (disclosed) transaction.
  • This is PanGenomic’s 1st transaction in Canada.
  • This is PanGenomic’s 1st transaction in British Columbia.

M&A Deal Summary
Date 2022-11-21
Target Mindleap Health
Sector Healthcare Services
Buyer(s) PanGenomic
Sellers(s) Mydecine Innovations Group
Deal Type Divestiture
Deal Value 4M CAD

Target

Mindleap Health

Vancouver, British Columbia, Canada
Mindleap Health is an advanced digital health platform that helps people connect with mental health specialists that can empower them to thrive and develop habits for a healthy mind. The company's online mental healthcare brings convenience, improves access to treatments, and can lead to more personal breakthroughs. Its proprietary platform is designed by clinical psychologists and neuroscientists to provide professional support and personalized treatment for every person. Mindleap Health was formed in 2019 and is based in Vancouver, British Columbia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

PanGenomic

Vancouver, British Columbia, Canada
Category Company
Founded 2015
Sector Healthcare Services
DESCRIPTION

PanGenomic improves the health and wellness of people by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual. PanGenomic was formed in 2015 and is based in Vancouver, British Columbia.

DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: British Columbia M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2022 M&A 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Mydecine Innovations Group

Toronto, Ontario, Canada
Category Company
Founded 2013
Sector Consumer Products
DESCRIPTION

Mydecine Innovations Group is a cannabidiol lifestyle company focused on the development, marketing, and distribution of CBD products (including vaporizer pens/cartridges, hot/cold tea, soft gel capsules, and beverages) throughout North America, South America, and Europe. Mydecine Innovations Group was founded in 2013 and is based in Toronto, Ontario.

DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: British Columbia M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2022 M&A 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-10 NeuroPharm

Vancouver, British Columbia, Canada

NeuroPharm, Inc. is a healthcare company that develops pharmaceutical and natural health products addressing mental wellness in vulnerable populations such as Veterans and Emergency Medical Services (EMS) personnel. NeuroPharm is based in Vancouver, British Columbia.

Buy $6M
Mergr

Solution for

Product

Company

Legal